![Ileen B. Winick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ileen B. Winick
Personalreferent bei
CANDEL THERAPEUTICS, INC.
Profil
Ileen B. Winick currently works at Candel Therapeutics, Inc., as Chief People Officer from 2021.
Ms. Winick also formerly worked at Casebia Therapeutics LLC, as Senior Vice President-Human Resources.
Ms. Winick received her graduate degree from Cornell University and undergraduate degree from the University of Cincinnati (Ohio).
Aktive Positionen von Ileen B. Winick
| Unternehmen | Position | Beginn |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Personalreferent | 01.01.2021 |
Ehemalige bekannte Positionen von Ileen B. Winick
| Unternehmen | Position | Ende |
|---|---|---|
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Personalreferent | - |
Ausbildung von Ileen B. Winick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
3
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cincinnati (Ohio)
 University of Cincinnati (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Discovers, develops and commercializes gene-editing therapeutics to treat the genetic causes of bleeding disorders, autoimmune disease | Health Technology |
